参考文献/References:
［1］钟方圆，罗金，谢青贞．子宫内膜异位症性不孕的研究进展 ［J］．中华生殖与避孕杂志，2019，39（7）：592595．
［2］Taylor H S,Giudice L C,Lessey B A, et al. Treatment of endometriosisassociated pain with elagolix, an oral GnRH antagonist ［J］. New England Journal of Medicine, 2017, 377 (1): 2840.
［3］Zondervan K T,Becker C M,Koga K, et al. Endometriosis ［J］.Nat Rev Dis Primers,2018,4(1):9.
［4］张丽，马彩虹，张馨雨，等．子宫内膜异位症合并不孕女性卵泡液细胞因子表达水平的研究 ［J/OL］．中华生殖与避孕杂志，2018,38（12）：986990．
［5］彭靖，张萌，李桂玲．子宫内膜异位症相关不孕的治疗进展 ［J］．国际生殖健康/计划生育杂志，2017，36（1）：8286．
［6］黄薇，刘冬.子宫内膜异位症相关不孕的助孕策略 ［J］.山东大学学报 (医学版),2019,57 (6):2326，32.
［7］Guo Sunwei. Genesis, genes and epigenetics of endometriosisassociated infertility ［J］. Nature Reviews Endocrinology, 2019, 15 (5): 259260.
［8］Chapron C,Marcellin L,Borghese B, et al. Rethinking mechanisms, diagnosis and management of endometriosis ［J］. Nature Reviews Endocrinology, 2019, 15 (11): 666682.
［9］Dumesic D A,Meldrum D R,KatzJaffe M G, et al. Oocyte environment: follicular fluid and cumulus cells are critical for oocyte health ［J］. Fertility and Sterility, 2015, 103 (2): 303316.
［10］宋翠淼，段彦苍，李文雅，等．卵母细胞分泌因子及其Smads信号通路与卵母细胞质量关系的研究进展 ［J］．吉林大学学报(医学版)，2016，42（2）：405408．
［11］吴小华，程立立，张敏，等．卵母细胞分泌因子在人卵丘颗粒细胞中的表达及其与卵母细胞发育潜能的关系 ［J］．生殖与避孕，2016，36（9）：701707．
［12］余雁，周丽，仝进毅，等.骨形态发生蛋白15(BMP15)/生长分化因子9(GDF9)在卵巢功能及女性生育过程中的作用 ［J］.生殖与避孕,2015,35(6):409414，430.
［13］Paulini F,Melo E O. The role of oocytesecreted factors GDF9 and BMP15 in follicular development and oogenesis ［J］. Reproduction in Domestic Animals, 2011, 46 (2): 354361.
［14］Field S L,Dasgupta T,Cummings M, et al. Cytokines in ovarian folliculogenesis,oocyte maturation and luteinisation ［J］. Molecular Reproduction and Development, 2014, 81 (4): 284314.
［15］Di Pasquale E,BeckPeccoz P,Persani L. Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein15 (BMP15) gene ［J］. American Journal of Human Genetics, 2004, 75 (1): 106111.
［16］Otsuka F,Shimasaki S. A negative feedback system between oocyte bone morphogenetic protein 15 and granulosa cell kit ligand: its role in regulating granulosa cell mitosis ［J］. Proceedings of the National Academy of Sciences of the United States of America, 2002, 99 (12): 80608065.
［17］Persani L,Rossetti R,Di Pasquale E, et al. The fundamental role of bone morphogenetic protein 15 in ovarian function and its involvement in female fertility disorders ［J］. Human Reproduction Update, 2014, 20 (6): 869883.
［18］Belli M,Shimasaki S.Molecular aspects and clinical relevance of GDF9 and BMP15 in ovarian function ［J］. Vitamins and Hormones, 2018, 107: 317348.
［19］B Wiweko,P A Iffanolida,Z Rectifa,et al. BMP15 mRNA profile in granulosa cells from endometriosis patients undergoing in vitro fertilization ［J］. Journal of Physics: Conference Series,2018,1073 (3)：032052.
［20］Sugira K, SU Youqiang, Diaz F J, et al. Oocytederived BMP15 and FGFs cooperate to promote glycolysis in cumulus cells ［J］.Development(Cambridge,England),2007,134(14):25932603.
［21］张永美，林小娜，周枫，等．骨形态蛋白 (BMP)15对子宫内膜异位症患者IVF结局影响的临床研究 ［J］．生殖与避孕，2012，32（11）：739743, 753．
［22］王秀芬，林小娜，戴永东，等．子宫内膜异位症患者卵泡液、卵泡刺激素骨形态发生蛋白15对颗粒细胞增殖及孕酮分泌的影响 ［J］．中华医学杂志，2017，97 （45）：35433547．
［23］Kedem A,Fisch B,Garor R, et al. Growth differentiating factor 9 (GDF9) and bone morphogenetic protein 15 both activate development of human primordial follicles in vitro, with seemingly more beneficial effects of GDF9 ［J］. The Journal of Clinical Endocrinology and Metabolism,2011,96 (8):E 1246E 1254.
［24］De Conto E,Matte U,Bilibio J P, et al. Endometriosisassociated infertility: GDF9, AMH, and AMHR2 genes polymorphisms ［J］. Journal of Assisted Reproduction and Genetics, 2017, 34 (12): 16671672.
［25］LI Yi,LI Ruiqi,Ou Songbang,et al.Increased GDF9 and BMP15 mRNA levels in cumulus granulosa cells correlate with oocyte maturation,fertilization,and embryo quality in humans ［J］.Reproductive Biology and Endocrinology:2014,12(1):81.
［26］Hendarto H,Prabowo P,Moeloek F A, et al. Growth differentiation factor 9 concentration in the follicular fluid of infertile women with endometriosis ［J］. Fertility and Sterility, 2010, 94 (2): 758760.
［27］Juengel J L,Mcnatty K P. The role of proteins of the transforming growth factorbeta superfamily in the intraovarian regulation of follicular development ［J］. Human Reproduction Update, 2005, 11 (2): 143160.
［28］Roh E Y,Yoon J H,Song E Y, et al. Single nucleotide polymorphisms in the TGFβ1 gene are associated with polycystic ovary syndrome susceptibility and characteristics: a study in Korean women ［J］. Journal of Assisted Reproduction and Genetics, 2017, 34 (1): 139147.
［29］Young V J,Ahamad S F,Duncan W C, et al. The role of TGFβ in the pathophysiology of peritoneal endometriosis ［J］. Human Reproduction Update, 2017, 23 (5): 548559.
［30］Chen Y C,Chang H M,Cheng J C, et al. Transforming growth factorβ1 upregulates connexin43 expression in human granulosa cells ［J］. Human Reproduction (Oxford, England), 2015, 30 (9): 21902201.
［31］许泓，钱羽力，徐键，等．子宫内膜异位症相关性不孕症患者卵泡液TGFβ1的测定和临床意义 ［J］．科技通报，2005，21（5）：561563．
［32］Gao Minzhi,Zhao Xiaoming,Lin Yi, et al. Effects of EGVEGF, VEGF and TGFβ1 on pregnancy outcome in patients undergoing IVFET treatment ［J］. Journal of Assisted Reproduction and Genetics, 2012, 29 (10): 10911096.
［33］Safdarian L,Ghalandarpoor Attar S N,Aleyasin A, et al. Investigation of antimullerian hormone (AMH) level and ovarian response in infertile women with endometriosis in IVF cycles ［J］. International Journal of Reproductive Biomedicine (Yazd, Iran), 2018, 16 (11): 719722.
［34］郑娟，侯振，祁晓晨，等．激活素A对子宫内膜异位症患者在位内膜间质细胞的调节作用 ［J］．生殖与避孕，2012，32（5）：316322．
相似文献/References:
[1]苏慧明,徐燕,李晶,等.E-钙粘附素在子宫内膜异位症盆腔腹膜病灶的表达[J].中国计划生育和妇产科,2010,(01):0.
SU Hui-ming,XU Yan,LI Jing,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(9):0.
[2]李桂兰.青春期子宫内膜异位症的诊治进展[J].中国计划生育和妇产科,2010,(03):0.
[3]韦晓娜,覃红萍.孕三烯酮配伍小剂量米非司酮治疗子宫内膜异位症64例效果观察[J].中国计划生育和妇产科,2010,(04):0.
[4]李成龙,冷金花.子宫内膜异位症与雌、孕激素受体关系的研究进展[J].中国计划生育和妇产科,2010,(04):0.
[5]关铮.深部浸润型子宫内膜异位症相关问题探讨[J].中国计划生育和妇产科,2011,(04):0.
[6]张瑞霞,刘增娟,谢伟,等.腹腔镜诊断盆腔子宫内膜异位症及对不孕症患者的疗效观察[J].中国计划生育和妇产科,2012,(02):0.
ZHANG Rui-xia,LIU Zeng-juan,XIE Wei,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(9):0.
[7]梁寿珺,范余娟,黄尹,等.血管内皮生长因子+936TC基因多态性同子宫内膜异位症遗传易感性的Meta分析[J].中国计划生育和妇产科,2012,(04):0.
LIANG Shou-jun,FAN Yu-juan*,HUANG Yin,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(9):0.
[8]范俊,栾少红,李晓林,等.口服避孕药在子宫内膜异位症治疗中的作用[J].中国计划生育和妇产科,2013,(02):0.
FAN Jun,LUAN Shao-hong,LI Xiao-lin,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(9):0.
[9]柴明涵,董白桦.左炔诺孕酮宫内缓释系统的临床应用[J].中国计划生育和妇产科,2014,(03):0.
[10]李素红,冯春蝶,付秀虹,等.Treg细胞及Foxp3在子宫内膜异位症患者的表达及临床意义[J].中国计划生育和妇产科,2014,(04):0.
LI Su-hong,FENG Chun-die,FU Xiu-hong,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(9):0.